Abstract
1,2-Dimethylhydrazine (DMH) is a plant toxicant that enters the food web through the diet. It is biotransformed into azoxymethane, a colon carcinogen, during the first hepatic passage. In mice, this study assessed the role of glutamate dehydrogenase (GDH), a key glutaminolysis enzyme in DMH-induced colorectal cancer (CRC). Colon samples were taken from mice given 6 or 15 weekly doses of 20 mg/kg DMH and serially sacrificed. Repeated DMH doses induced early aberrant crypt foci that evolved into irreversible adenocarcinomas over 24 weeks, along with an increase in GDH and lactate dehydrogenase activities (+ 122%, + 238%, P < 0.001), indicating a switch to aerobic glycolysis and glutaminolysis. Transcriptional downregulation of the endogenous GDH inhibitor, sirtuin4, and two redox regulators, mitochondrial sestrin2 and nuclear factor (erythroid derivative 2)-like 2 (− 26% and − 22%, P < 0, 05; and − 30%, P < 0.01), exacerbated mitochondrial stress by boosting mitochondrial superoxide dismutase activity (+ 240% (P < 0.001) while depressing catalase activity and GSH levels (− 57% and − 60%, P < 0.001). In vitro, allosteric GDH inhibition by 50 µM epigallocatechin gallate decreased human carcinoma (HCT-116) cells’ viability, clonogenicity, and migration (− 43% and − 57%, P < 0.001, 41%, P < 0.05), while stimulating ROS release (+ 57%, P < 0.001). Dimethylfumarate (DMF), a linear electrophile and mitochondrial fumarate analog, rebalanced ROS levels (− 34%, P < 0.05) and improved GDH activity, cell viability, and tumorogenic capacity (+ 20%, 20%, P < 0.001; and 33%, P < 0.05). Thus, the pathological remodeling of colon mucosa is supported by metabolic reprogramming bypassing uncoupled mitochondria. DMF highlights the critical role of electrophile response elements in modulating redox mithormesis and redox homeostasis during CRC.
Graphical Abstract
Similar content being viewed by others
Data availability
All histological, immunochemical, biochemical, and RT-PCR data are available upon request from the first author.
Abbreviations
- AOM:
-
Azoxymethane
- BCH:
-
2-Aminobicyclo-(2,2,1)-heptane-2-carboxylic acid
- DMF:
-
Dimethylfumarate
- DMH:
-
1,2-Dimethylhydrazine
- E-Cad:
-
E-cadherin
- EGCG:
-
Epigallocatechin gallate
- Ep/ARE:
-
Electrophile/antioxidants response elements
- GDH:
-
Glutamate dehydrogenase
- GSH:
-
Reduced glutathione
- GLUT:
-
Glucose transporter
- MDZ:
-
Methyldiazonium
- MAM:
-
Methylcarbabonium
- CH3+ :
-
Methyl cation
- MnSOD:
-
Manganese superoxide dismutase
- mtROS:
-
Mitochondrial reactive oxygen species
- mtO2 − :
-
Mitochondrial superoxide anion
- NAC:
-
N-acetylcysteine
- Nrf2:
-
Nuclear factor (erythroid-derived 2)-like 2
- PTEN:
-
Phosphatase and tensin homolog
- ROS:
-
Reactive oxygen species
- Sesn2:
-
Sestrin2
- Sirt4:
-
Sirtuin4
- α-SMA:
-
α-Smooth muscle actin
References
Aebi H (1984) Catalase in vitro Methods. Enzymol 105(121):26
Aggarwal V, Tuli HS, Varol A, Thakral F, Yerer MB, Sak K, Varol M, Jain A, Md A, Sethi G (2019) Role of reactive oxygen species in cancer progression: molecular mechanisms and recent advancements. Biomolecules 9(11):735
Aguilar E, Esteves P, Sancerni T, Lenoir V, Aparicio T, Bouillaud F, Dentin R, Prip-Buus C, Ricquier D, Pecqueur C, Guilmeau S, Alves-Guerra MC (2019) UCP2 deficiency increases colon tumorigenesis by promoting lipid synthesis and depleting NADPH for antioxidant defenses. Cell Rep 28(9):2306–2316
Altmeyer P, Matthes U, Pawlak F, Hoffmann K, Frosch P, Ruppert P (1994) Antipsoriatic effect of fumaric acid derivatives. Results of a multicenter double-blind study in 100 patients. J Am Acad Dermatol 30:977–981
Arnold P, Mojumder D, Detoledo J, Lucius R, Wilms H (2014) Pathophysiological processes in multiple sclerosis: focus on nuclear factor erythroid-2-related factor 2 and emerging pathways. Clin Pharmacol 6:35–42
Ashrafian H, Czibik G, Bellahcene M, Aksentijevic D, Smith AC, Mitchel SJ, Dodd MS, Kirwan J, Byrne JJ, Ludwig C, Isackson H, Yavari A, Støttrup NB, Contractor H, Thomas Cahill TJ, Sahgal N, Ball DR, Birkler RID, Hargreaves I, Tennant DA, Land J, Lygate CA, Johannsen M, Kharbanda RK, Neubauer S, Redwood C, de Cabo R, Ahmet I, Talan M, Günther UL, Robinson AJ, Viant MR, Pollard PJ, Tyler DJ, Watkins H (2012) Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway. Cell Metab 15:361–371
Aspuria PJP, Lunt SY, Väremo L, Vergnes L, Gozo M, Beach JA, Salumbides B, Reue K, Wiedemeyer WR, Nielsen J, Karlan BY, Orsulic S (2014) Succinate dehydrogenase inhibition leads to epithelial-mesenchymal transition and reprogrammed carbon metabolism. Cancer Metab 2:21
Avolio R, Matassa DS, Criscuolo D, Landriscina M, Esposito F (2020) Modulation of mitochondrial metabolic reprogramming and oxidative stress to overcome chemoresistance in cancer. Biomolecules 10(1):135
Ayala A, Muñoz MF, Sandro Argüelles S (2014) Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Medic Cell Longev 2014:360438
Baryła M, Semeniuk-Wojta´s A, Róg L, Kraj L, Małyszko M, Stec R, (2022) Oncometabolites—a link between cancer cells and tumor microenvironment. Biology (basel) 11(2):270
Bekusova V, Falchuk EL, Okorokova LS, Kruglova NM, Nozdrachev AD, Markov AG (2018) Increased paracellular permeability of tumor-adjacent areas in 1,2-dimethyhydrazine-induced colon carcinogenesis in rats. Cancer Biol Med 15:251–259
Belisario DC, Kopecka J, Pasino M, Akman M, De Smaele E, Donadelli M, Riganti C (2020) Hypoxia dictates metabolic rewiring of tumors: implications for chemoresistance. Cells 9:2598
Bird RP, Good CK (2000) The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicol Lett 112:395–402
Bounaama A, Djerdjouri B, Laroche-Clary A, Le Morvan V, Robert J (2012) Short curcumin treatment modulates oxidative stress, arginase activity, aberrant crypt foci, and TGF- 1 and HES-1 transcripts in 1,2-dimethylhydrazine-colon carcinogenesis in mice. Toxicology 302(308):17
Brabletz S, Schuhwerk H, Brabletz T, Stemmler MP (2021) Dynamic EMT: a multi-tool for tumor progression. EMBO J 40:e108647
Brand MD (2010) The sites and topology of mitochondrial superoxide production. Exp Gerontol 45(7–8):466–472
Brandi J, Cecconi D, Cordani M, Torrens-Mas M, Pacchiana R, DallaPozza E, Butera G, Manfredi M, Marengo E, Oliver J, Roca P, Dando I, Donadelli M (2016) The antioxidant uncoupling protein 2 stimulates hnRNPA2/B1, GLUT1 and PKM2 expression and sensitizes pancreas cancer cells to glycolysis inhibition. Free Radic Biol Med 101:305–316
Cavanna M, Parodi S, Taningher M, Bolognesi C, Sciaba L, Brambilla G (1979) DNA fragmentation in some organs of rats and mice treated with cycasin. Br J Cancer 39:383
Colvin H, Nishida N, Konno M, Haraguchi N, Takahashi H, Nishimura J, Hata T, Kawamoto K, Asai A, Tsunekuni K, Koseki J, Mizushima T, Satoh T, Doki Y, Mori M, Ishii H (2016) Oncometabolite D-2-Hydroxyglurate directly induces epithelial-mesenchymal transition and is associated with distant metastasis in colorectal cancer. Sci Rep 6:36289
Crabtree HG (1929) Observations on the carbohydrate metabolism of tumours. Biochem J 23:536–545
Cullinan SB, Zhang D, Hannink M, Arvisais E, Kaufman RJ, Diehl JA (2003) Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Mol Cell Biol 20:7198–7209
Daniel Y, Lelou E, Aninat C, Corlu A, Cabillic F (2021) Interplay between metabolism reprogramming and epithelial-to-mesenchymal transition in cancer stem cells. Cancers (basel) 13:1973
DeBerardinis RJ, Chandel NS (2016) Non-essential amino acids serve as precursors to purine and pyrimidine synthesis and methyl groups are obtained from the carbon (1C)/folate pool. Fundamentals of Cancer Metabolism Sci Adv 2:e1600200
Denizot F, Lang R (1986) Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89:271–277
Ellman G (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82(1):70–77
Femia AP, Luceri C, Toti S, Giannini A, Dolara P, Caderni G (2010) Gene expression profile and genomic alterations in colonic tumours induced by 1,2-dimethylhydrazine (DMH) in rats. BMC Cancer 10:194
Fiala E (1975) Carcinogen 1,2-dimehylhydrazine: mode of action of the colon. Cancer 36:2407–2412
Gaude E, Schmidt C, Gammage PA, Dugourf A, Blacker T, Chew SP, Saez Rodriguez J, O’Neill JS, Szabadkai G, Minczuk M, Frezza C (2018) NADH shuttling couples cytosolic reductive carboxylation of glutamine with glycolysis in cells with mitochondrial dysfunction. Mol Cell 69(4):581–593
Grazziano F, Ruzzo A, Giacomini E, Ricciardi T, Aprile G, Loupakis F, Lorenzini P, Ongaro E, Zoratto F, Catalano V, Sari D, Rulli E, Cremolini C, De Nictolis M, De Maglio G, Falcone A, Fiorentini G, Magnani M (2017) Glycolysis gene expression analysis and selective metabolic advantage in the clinical progression of colorectal cancer. Pharmacogenomics J 17(3):258–264
Haigis MC, Mostoslavsky R, Haigis KM, Fahie K, Christodoulou DC, Murphy AJ, Valenzuela DM, Yancopoulos GD, Karow M, Blandre G, Wolberger C, Prolla TA, Weindruch R, Alt FW, Guarente L (2006) SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell 126(5):941–945
Hanna N, Woods C, Zheng Z, Onukwugha E, Seal BS, Mullins CD (2014) Survival benefit associated with the number of chemotherapy/biologic treatment lines in 5,129 metastatic colon cancer patients. J Clin Oncol 32(3):559–559. https://doi.org/10.1200/jco.2014.32.3_suppl.559
Harris IS, Treloar AE, Inoue S, Sasaki M, Gorrini C, Lee KC, Yung KY, Brenner D, Knobbe-Thomsen CB, Cox MA, Elia E, Berger T, Cescon DW, Adeoye A, Brustle A, Molyneux SD, Mason JM, Li WY, Yamamoto K, Wakeman A, Berman HK, Khokha SJ, Done SJ, Kavanagh TJ, Lam CW, Mak TW (2015) Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression. Cancer Cell 27(2):211–222
Hayes JD, Dinkova-Kostova AT (2014) The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem Sci 39(4):199–218
Herron DC, Shank RC (1981) In Vivo Kinetics of O6-methylguanine and 7-methylguanine formation and persistence in DMA of rat treated with symmetrical dimethylhydrazine. Cancer Res 41(3967):72
Hirayama A, Kami K, Sugimoto M, Sugawara M, Toki N, Onozuka H, Kinoshita T, Saito N, Ochiai A, Tomita M, Esumi H (2009) Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res 69(11):4918–4925
Holmuhamedov EL, Jovanovic S, Dzeja PP, Jovanovic A, Terzic A (1998) Mitochondrial ATP-sensitive K+ channels modulate cardiac mitochondrial function. Am J Physiol 275:H1567–H1576
Huang G, Cheng J, Yu F, Liu X, Chen X, Peng Z (2016) Clinical and therapeutic significance of sirtuin 4 expression in colorectal cancer. Oncol. Rep. 35(5):2801–2810
Jia D, Park JH, Kaur H, Jung KH, Yang S, Tripathi S, Galbraith M, Deng Y, Jolly MK, Kaipparettu BA, Onuchic JN, Levine H (2021) Towards decoding the coupled decision-making of metabolism and epithelial-to-mesenchymal transition in cancer. Br J Can 124:1902–1911
Jin L, Li D, Alesi GN, Fan J, Kang HB, Lu Z, Boggon TJ, Jin P, Yi H, Wright ER, Duong D, Seyfried NT, gnatchik R, Deberardinis RJ, Magliocca KR, He C, Arellano ML, Khoury HJ, Shin DM, Khuri FR, Kang S, (2015) Glutamate dehydrogenase 1 signals through antioxidant glutathione peroxidase 1 to regulate redox homeostasis and tumor growth. Cancer Cell 27(2):257–270
Kanehara K, Ohnuma S, Kanazawa Y, Sato K, Kokubo S, Suzuki H, Kaeasawa H, Suzuki T, Suzuki C, Naitoh T, Unno M, Abe T (2019) The indole compound MA-35 attenuates tumorigenesis in an inflammation-induced colon cancer model. Sci Rep 9:12739
Kovacevic Z (1971) The pathway of glutamine and glutamate oxidation in isolated mitochondria from mammalian cells. Biochem J 125(3):757–763
Lee SR, Yang KS, Kwon J, Lee C, Jeong W, Rhee SG (2002) Reversible inactivation of the tumor suppressor PTEN by H2O2. J Biol Chem 277(23):20336–20342
Leone A, Roca MS, Ciardiello C, Costantini S, Budillon A (2017) Oxidative stress gene expression profile correlates with cancer patient poor prognosis: identification of crucial pathways might select novel therapeutic approaches. Oxid Med Cell Longev 2017:2597581
Li W, Nichols K, Nathan CA, Zhao Y (2013) Mitochondrial uncoupling protein 2 is up-regulated in human head and neck, skin, pancreatic, and prostate tumors. Cancer Biomark 13(5):377–383
Liang CC, Park AY, Guan JL (2007) In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2:329–333
Liao S, Umekita Y, Guo J, Kokontis JM, Hiipakka RA (1995) Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate. Cancer Lett 96(2):239–243
Manna SK, Tanaka N, Krausz KW, Haznadar M, Xue X, Matsubara T, Bowman ED, Fearon ER, Harris CC, Shah YM, Gonzalez FJ (2014) Biomarkers of coordinate metabolic reprogramming in colorectal tumors in mice and humans. Gastroenterology 146(5):1313–1324
Marklund S, Marklund G (1974) Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47:469–474
Mathias RA, Greco TM, Oberstein A, Budayeva HG, Chakrabarti R, Rowland EA, Kang Y, Shenk T, Cristea I (2014) Sirtuin 4 is a lipoamidase regulating pyruvate dehydrogenase complex activity. Cell 159(7):1615–1625
Matsumoto H, Higa HH (1966) Studies on methylazoxymethanol, the aglycone of cycasin: methylation of mucleic acids in vitro. Biochem J 98(20c):22c
Mishra D, Banerjee D (2019) Lactate dehydrogenases as metabolic links between tumor and stroma in the tumor microenvironment. Cancers (basel) 11(6):750
Miyo M, Yamamoto H, Konno M, Colvin H, Nishida N, Koseki J, Kawamoto K, Ogawa H, Hamabe A, Uemura M, Nishimura J, Hata T, Takemasa I, Mizushima T, Doki Y, Mori M, Sshii H (2015) Tumour-suppressive function of SIRT4 in human colorectal cancer. Br J Can 113(3):49299
Mouzaoui S, Banerjee S, Djerdjouri B (2020) Low-dose curcumin reduced TNBS-associated mucin depleted foci in mice by scavenging superoxide anion and lipid peroxides, rebalancing matrix NO synthase and aconitase activities, and recoupling mitochondria. Inflammopharm. 28(4):949–965
Nagasawa HT, Shirota FN, Matsumota H (1972) Decomposition of methylazoxymethanol. The aglycone of cycasin, in DO. Nature 236:234–235
Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Meyerhardt JA, Loda M, Giovannucci EL, Fuchs CS (2009) CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut 58(1):90–96
Orrenius S, Gogvadze V, Zhivotovsky B (2007) Mitochondrial oxidative stress: implications for cell death. Annu Rev Pharmacol Toxicol 47:143–183
Ortmayr K, Dubuis S, Zampieri M (2009) Metabolic profiling of cancer cells reveals genome wide crosstalk between transcriptional regulators and metabolism. Nature Commun 10:1841
Pan Q, Lou X, Zhang J, Zhu Y, Li F, Shan Q, Chen X, Xie Y, Su S, Wei H, Lin L, Wu L, Liu S (2017) Genomic variants in mouse model induced by azoxymethane and dextran sodium sulfate improperly mimic human colorectal cancer. Sci Rep 1:25
Park HW, Park H, Ro SH, Semple JA, Kim DN, Kim M, Nam M, Yin L, Lee JH (2014) Hepatoprotective role of Sestrin2 against chronic ER stress. Nat Commun 5:4233
Pasha M, Eid AH, Eid AA, Gorin Y, Munusamy S (2017) Sestrin2 as a novel biomarker and therapeutic target for various diseases. Oxid Med Cell, Longev, pp 3296294–3296294
Perse P, Cerar A (2011) Morphological and molecular alterations in 1,2 dimethylhydrazine and azoxymethane induced colon carcinogenesis in rats. J Biomed Biotechnol 2011:473964
Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45
Pollard PJ, Brière JJ, Alam NA, Barwell J, Barclay E, Wortham NC, Hunt T, Mitchell M, Olpin S, Moat SJ, Hargreaves IP, Heales SJ, Chung YL, Griffiths JR, Dalgleish A, McGrath IA, Gleeson MJ, Hodgson SV, Poulsom R, Rustin P, Tomlinson IPM (2005) Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum Mol Genet 14(15):2231–2239
Porporato PE, Payen VL, Perez-Escudo J, De Saedeleer CJ, Danhier P, Copetti T, Dhup S, Tardy M, Vazeille T, Bouzin C, Feron O, Michiels C, Gallez B, Sonveaux P (2014) Mitochondrial switch promotes tumor metastasis. Cell Rep 8:754–766
Ro SH, Xue X, Ramakrishnan SK, Cho CS, Namkoong S, Jang I, Semple IA, Ho A, Park HW, Shah YMn Lee JH (2016) Tumor suppressive role of Sestrin2 during colitis and colon carcinogenesis. Elife 5:e12204
Saito R, Suzuki T, Hiramoto K, Asami S, Naganuma E, Suda H, Iso T, Yamamoto H, Morita M, Baird L, Furusawa Y, Negishi T, Ichinose M, Yamamoto M (2016) Characterizations of three major cysteine sensors of keap1 in stress response. Mol Cell Biol 36(2):271–284
Sarsour EH, Kalen AL, Goswami PC (2014) Manganese superoxide dismutase regulates a redox cycle within the cell cycle. Antioxid Redox Signal 20(10):1618–1627
Satoh T, Lipton SA (2007) Redox regulation of neuronal survival by electrophilic compounds. Trends Neurosci 30:38–45
Satoh K, Yachida S, Sugimoto M, Oshima M, Nakagawa T, Akamoto S, Tabata S, Saitoh K, Kato K, Sato S, Igarachi K, Aizawa Y, Kajino-Sakamoto R, Kojima Y, Fujishita T, Enomoto A, Hirayama A, Ishakawa T, Taketo MM, Kushida Y, Haba R, Okano K, Tomita M, Susuki Y, Fukuda S, Aoki M, Soga T (2017) Global metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYC. Proc Natl Acad Sci USA 114:E7697-e7706
Scannevin RH, Chollate S, Jung MY, Shackett M, Patel H, Bista P, Zeng W, Ryan S, Yamamoto M, Lukashev M, Rhodes KJ (2012) Fumarates promote cytoprotection of central nervous system cells against oxidative stress via the nuclear factor (erythroid-derived 2)-like 2 pathway. J Pharmacol Exp Ther 341(1):274–284
Sciacovelli M, Frezza C (2017) Fumarate drives EMT in renal cancer. Cell Death Differ 24:1–2
Snezhkina AV, Kudryavtseva AV, Kardymon OL, Savvateeva MV, Melnikova NV, Krasnov GS, Dmitriev AA (2019) ROS generation and antioxidant defense systems in normal and malignant cells oxid. Med Cell Longev 5:2019
Sohn OS, Fiala ES, Requeijo SO, Weisburger JH, Gonzalez FJ (2001) Differential effects of CYP2E1 status on the metabolic activation of the colon carcinogens azoxymethane and methylazoxymethanol. Cancer Res 61(23):8435–8440
Spinelli JB, Yoon H, Ringel AE, Jeanfavre S, Clish CB, Haigis MC (2017) Metabolic recycling of ammonia via glutamate dehydrogenase supports breast cancer biomass. Sci 358:941–946
Steelman LS, Abrams SL, Whelan J, Libra M, Stivala F, Milella M, Tafuri A, Lunghi P, Bonati A, Martelli AM, McCubrey AJ (2008) Contributions of the Raf/MEK/ ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia. Leukemia 22:686–707
Stincone A, Prigione A, Cramer T, Wamelink MM, Campbell K, Cheung E, Cheung E, Olin-Sandoval V, Grüning NM, Krüger A, Alam MT, Keller MA, Breitenbach M, Brindle KM, Rabinowitz JD, Ralser M (2016) The return of metabolism: biochemistry and physiology of the pentose phosphate pathway. Biol Rev Camb Philos Soc 90:927–963
Sun H, Huang D, Liu G, Jian F, Zhu J, Zhang L (2018) SIRT4 acts as a tumor suppressor in gastric cancer by inhibiting cell proliferation, migration, and invasion. Onco Targets Ther 11:3959–3968
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249
Tardito S, Oudin A, Ahmed SU, Fack F, Keunen O, Zheng L, Miletic H, Sakariassen PO, Weinstock A, Wagner A, LindsaySL HAK, Barett SC, Ruppin E, Mørkve SH, LundJohansen M, Chalmers AJ, Bjerkvig R, Niclou SP, Gottlieb E (2015) Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma. Nature Cell Biol 17:1556–1568
Valcourt U, Kowanetz M, Niimi H, Heldin CH, Moustakas A (2006) TGF and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol Biol Cell 16:1987–2002
Vozza A, Parisi G, de Leonardis F, Lasorsa FM, Castegna A, Amorese D, Marmo R, Calcagnile VM, Palmieri L, Ricquier D, Paradies E, Scarcia P, Palmieri F, Bouillaud F, Fiermonte G (2014) UCP2 transports C4 metabolites out of mitochondria, regulating glucose and glutamine oxidation. Proc Natl Acad Sci USA 111:960–965
Walter P, Ron D (2011) The unfolded protein response: from stress pathway to homeostatic regulation. Sci 334:1081–1086
Wang Y, Qi H, Liu Y, Duan C, Liu X, Xia T, Chen D, Piao HL, Liu HX (2021) The double-edged roles of ROS in cancer prevention and therapy. Theranostics 11(10):4839–4857
Warburg O (1956) On the origin of cancer cells. Sci 123:309–314
Weinhouse S (1956) On respiratory impairment in cancer cells. Science 124:267–269
Whitaker-Menezes D, Martinez-Outschoorn UE, Lin Z, Ertel A, Flomenberg N, Witkiewicz AK, Birbe RC, Howell A, Pavlides S, Gandara R, Pestell RG, Sotgia FS, Philp NJ, Lisanti MP (2011) Evidence for a stromal-epithelial “lactate shuttle” in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts. Cell Cycle 10:1772–1783
Wise DR, DeBrardinis RJ, Mancuso A, Sayed N, Zhang XY, Pfeiffer HK, Nissim I, Daikhin E, Yudkoff M, McMahon SB, Thompson CB (2008) Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci USA 105(48):18782–18787
Woo DK, Green PD, Santos JH, D’Souza AD, Walther Z, Martin WD, Christian BE, Chandel NS, Shadel GS (2012) Mitochondrial genome instability and ROS enhance intestinal tumorigenesis in APCMin/+ mice. Am J Pathol 180:24–31
Xiao M, Yang H, Xu W, Ma S, Lin H, Zhu H, Liu L, Ying Liu Y, Yang C, Xu Y, Zhao S, Ye D, Xiong Y, Guan KL (2012) Inhibition of alpha-KG dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev 26:1326–3138
Zaleski J, Wilson DF, Erecinska M (1986) 2-Aminobicyclo-(2.2.1)-heptane-2-carboxylic acid, a new activator of glutaminase in intact rat liver mitochondria. J Biol Chem 261(30):14091–10494
Zelko IN, Mariani TJ, Folz RJ (2022) Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) Gene Structures, Evolution, and Expression. Free Radic Biol Med 33:337–349
Zhang Y, Park J, Han SJ, Yang SY, Yoon HJ, Park I, Woo HA, Lee SR (2020) Redox regulation of tumor suppressor PTEN in cell signaling. Red Biol 34:101553
Zhu Y, Richardson JA, Parada LF, Graff JM (1998) Smad3 mutant mice develop metastatic colorectal cancer. Cell 94:703–714
Acknowledgements
We acknowledge all the staff of the Laboratory of Pharmacology (University of Porto, Portugal) for their valuable scientific contribution to this study.
This study was supported in part by the “Direction Générale de la Recherche Scientifique et du Development Technique (DG-RSDT),” Algiers, Algeria.
Author information
Authors and Affiliations
Contributions
BD, JG, and BA designed the research. AB contributed to the experimental tumorigenesis protocol. BA, DS, and CQ conducted experiments. SYD made the histological and immunohistological evaluations. BD, JG, and BA analyzed data and wrote the manuscript. BD revised the manuscript.
Corresponding author
Ethics declarations
Ethical approval
All the in vivo experiments were carried out in agreement with the Ethics Committee for Animal Welfare of the University of Science and Technology Houari Boumediene (Algiers) [Algerian Law 12–235/2012; Executive Decree No. 10–90] and in accordance with the European Directive 2010/63/EU for ethics in animal experimentation.
Consent to participate and for publication
All authors consent to participate in this study. They read and approved the manuscript. The authors declare that all data were generated in-house and that no paper mill was used.
Competing interests
Not applicable.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Highlights
• 1,2-Dimethylhydrazine (DMH) depresses Sesn2 and Nrf2 and redox homeostasis.
• Long-term DMH supports glutamate dehydrogenase (GDH) activity by blocking sirtuin4.
• the burst in matrix superoxide dismutase activity induced mitochondrial stress.
• Dimethylfumarate (DMF) rescued GDH activity inhibited by epigallocatechin gallate.
• DMF triggers GDH-mediated cancer cell's viability, motility and clogenicity.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Allal, BE., Bounaama, A., Silva, D. et al. Long-term 1,2-dimethylhydrazine triggers pathological remodeling of colon mucosa through repression of sestrin2, nuclear factor (erythroid-derived 2)-like 2, and sirtuin4 stimulating mitochondrial stress and metabolic reprogramming. Naunyn-Schmiedeberg's Arch Pharmacol 396, 1291–1307 (2023). https://doi.org/10.1007/s00210-023-02403-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-023-02403-x